Back

Coronary physiology: no complete diagnosis without acteylcholine

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Detection of microvascular dysfunction (2) Intracoronary Flow and Pressure Measurements ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Darach O h-Ici

Galway Clinic, Galway (Ireland)

5 More presentations in this session

Presentation thumbnail
Predictive factors and gender insights into abnormal myocardial flow reserve in non-obstructive coronary artery disease: a CZT-SPECT analysis
Professor K. Chen (Tianjin, CN)
Abstract Slides Video
Presentation thumbnail
The influence of epicardial resistance on Microvascular Resistance Reserve (MRR)
Doctor T. Mahendiran (Aalst, BE)
Abstract Slides Video
Presentation thumbnail
The relationship between coronary microvascular dysfunction and left ventricular longitudinal systolic function in patients with diabetes mellitus
Professor Y. Wang (Kunming, CN)
Abstract Slides Video
Presentation thumbnail
Coexistence of coronary microvascular dysfunction and left ventricular hypertrophy can predict prognosis of patients with nonobstructive coronary arteries.
Doctor A. Ito (Yokosuka, JP)
Abstract Slides Video
Presentation thumbnail
Temporal changes in FFR in initially deferred vessels in symptomatic patients
Mr R. Shuja (Russellville, US)
Abstract Slides Video

Access the full session

Session thumbnail
Detection of microvascular dysfunction (2)

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Procedural complications during intracoronary acetylcholine provocation testing in patients with cardiac arrest
thumbnail
Congress Presentation
Rethinking the false positive exercise stress test in the context of coronary microvascular dysfunction
thumbnail
Congress Presentation
Assessment of TIMI frame count pre- and post- intracoronary acetylcholine administration in patients with angina and non-obstructive coronary arteries (ANOCA)

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources